Page last updated: 2024-12-05

2-hydroxyquinoxaline

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-Hydroxyquinoxaline is a heterocyclic compound with a broad range of biological activities, including antibacterial, antifungal, and anticancer properties. Its synthesis often involves the condensation of o-phenylenediamine with a suitable α-hydroxycarbonyl compound. The compound has shown promise in various studies, exhibiting significant inhibitory effects against certain bacterial strains and fungal species. Its unique structural features, particularly the presence of the hydroxyl group, contribute to its biological activity. The compound is often studied to explore its potential as a drug candidate for various infectious diseases and conditions.'

quinoxalin-2-ol : A hydroxyquinoxaline that consists of quinoxaline having a single hydroxy substituent located at position 2. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID14526
CHEBI ID38890
SCHEMBL ID37862
MeSH IDM0258908

Synonyms (65)

Synonym
ai3-22771
nsc 13154
einecs 214-815-6
BB 0218319
quinoxalin-2-ol
AB-323/25048501
2-quinoxalinone
nsc-13154
2-hydroxyquinoxaline
1196-57-2
2(1h)-quinoxalinone
nsc13154
quinoxalin-2-one
3-quinoxalinone
2-quinoxalinol
wln: t66 bn enj cq
2-quinoxalone
2-hydroxy quinoxaline
inchi=1/c8h6n2o/c11-8-5-9-6-3-1-2-4-7(6)10-8/h1-5h,(h,10,11
2-quinoxalinol, 99% (hplc)
HMS1623H17
1h-quinoxalin-2-one
H0591
AKOS000120904
AKOS003236140
A804334
STL139322
quinoxalin-2(1h)-one
1,2-dihydroquinoxalin-2-one
144499-26-3
quinoxalin-2-(1h)-one
FT-0688667
2-quinoxinol
CHEBI:38890
FT-0612639
AM100249
SCHEMBL37862
quinoxalinone
2-keto-1,2-dihydroquinoxaline
quinoxaline-2-ol
2-hydroxy-benzopyrazine
DTXSID6061604
SY013680
mfcd00006722
TS-01898
2-quinoxalinol(9ci)
W-108501
AC-23582
F1775-0040
Z56824051
CS-W018235
F16123
Q27118020
CCG-321752
BCP30468
2-hydroxyquinoxaline pound>>quinoxalin-2-ol pound>>quinoxalin-2(1h)-one pound>>1,2-dihydroquinoxalin-2-one
EN300-16930
doi:10.14272/ffryuavnpbueic-uhfffaoysa-n.1
10.14272/FFRYUAVNPBUEIC-UHFFFAOYSA-N.1
quinalphos free hydroxy
P50007
doi:10.14272/ffryuavnpbueic-uhfffaoysa-n.2
10.14272/FFRYUAVNPBUEIC-UHFFFAOYSA-N.2
10.14272/FFRYUAVNPBUEIC-UHFFFAOYSA-N.3
doi:10.14272/ffryuavnpbueic-uhfffaoysa-n.3
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
hydroxyquinoxaline
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (11.11)18.2507
2000's4 (44.44)29.6817
2010's4 (44.44)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 32.30

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index32.30 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.96 (4.65)
Search Engine Demand Index35.70 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (32.30)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]